Corporate News
Cryo‑Cell International Inc. (ticker CCEL) experienced a modest yet noteworthy rise in its share price during a 24‑hour trading window that concluded at 03:13 AM Central European Time on Wednesday, 21 March 2026. The stock advanced 5.2 %, closing at approximately USD 4.75 on several major exchanges.
Market Snapshot
- Shares Outstanding: 8.1 million
- Market Capitalisation: USD 35.6 million
- Volume Traded in Last 24 Hours: USD 36.7 k
- Year‑to‑Date Performance: 31.73 % gain since the end of the previous month
- 200‑Day Simple Moving Average (SMA): USD 3.62
- 52‑Week High: USD 4.90 (recorded 21 August 2026)
- 52‑Week Low: USD 2.72 (recorded 25 March 2026)
Comparative Performance
Within the same 24‑hour period, several peer companies in the biotechnology and telecommunications sectors posted declines:
| Company | Ticker | 24‑Hour Change | Current Price | Market Cap |
|---|---|---|---|---|
| Comtech Telecommunications | CMTL | -1.44 % | USD 1.32 | USD 41.9 million |
| Sanuwave Health | SNWV | -2.62 % | USD 5.27 | USD 42.7 million |
| Annovis Bio | ANVS | -3.03 % | USD 0.98 | USD 42.3 million |
| Dogwood Therapeutics | DWTX | -0.82 % | USD 1.15 | USD 41.5 million |
| Aldeyra Therapeutics | ALDX | -5.00 % | USD 0.73 | USD 42.2 million |
The contrast between Cryo‑Cell’s upward trajectory and the broader market downturn illustrates the company’s relative resilience in a sector marked by volatility.
Company Overview
Cryo‑Cell International Inc. is a U.S.-based healthcare provider headquartered in Oldsmar, Florida. The firm specialises in cellular storage technology and devices, with a primary focus on the cryopreservation of umbilical cord blood stem cells. Cryo‑Cell operates its own cryopreservation facility in Clearwater, Florida, leveraging its proprietary expertise to store stem cells for future therapeutic use. The company’s services are detailed on its website, www.cryo-cell.com , and it trades on the NYSE MKT under the ticker CCEL. Cryo‑Cell’s initial public offering was completed on 21 January 1997.
This article is intended to provide a concise, factual overview of Cryo‑Cell International Inc.’s recent trading activity and market context. All figures are as of the specified trading window and may change with subsequent market movements.
